WALTHAM, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS) announced today that it will release its fourth quarter and full year 2018 financial results on Thursday, February 28, 2019. The Company will host a conference call and live audio webcast at 4:30 p.m. ET that day to discuss the results and provide a company update.

Conference Call Information: Date: Thursday, February 28, 2019 Time: 4:30 p.m. ET Domestic Dial-In Number: (866) 323-7965 International Dial-In Number: (346) 406-0961 Conference ID: 2468547

A replay of the conference call/webcast will be available from February 28 th at 7:30 pm ET and will be archived on the Company's website for 90 days. To access the replay, dial (855) 859-2056 U.S. or (404) 537-3406 for International, using conference ID number 2468547.

The live audio webcast of the call can be accessed from the Investors section of the Company’s website, www.radiuspharm.com . The full text of the announcement and financial results will also be available on the Company’s website.

About Radius

Radius is a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine therapeutics in the areas of osteoporosis and oncology. For more information, please visit www.radiuspharm.com .

Investor & Media Relations Contact:

Elhan Webb, CFA Email: ewebb@radiuspharm.com   Phone: 617-551-4011